fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

In the drive to deprescribe, heartburn drug study teaches key lessons

Written by | 15 Apr 2024

Whether it’s costs, safety risks or “pill fatigue” they’re trying to reduce, many health systems and clinics have started working on ways to encourage deprescribing of medications that… read more.

Pilot anticholinergic deprescribing scheme found that memory assessment in patients with reduced anticholinergic load improved significantly after two weeks

Written by | 9 Mar 2024

Much has been written about deprescribing of medicines with anticholinergic effects to reduce overall anticholinergic burden and it is widely recommended as a way to reduce cognitive impairment,… read more.

Examining when to get off meds for multiple sclerosis

Written by | 2 Aug 2023

Researchers at the Population Health Outcomes and Pharmacoepidemiology Education and Research Center (P-HOPER Center) at the University of Houston College of Pharmacy are examining when older patients with… read more.

Deprescribing to optimise drug therapy

Written by | 27 Apr 2023

Debi Bhattacharya is Professor of Behavioural Medicine at the University of Leicester, UK. As a former primary care pharmacist, she has experience of both practice and research into… read more.

CHARMER – a different kind of deprescribing intervention study

Written by | 26 Apr 2023

The CHARMER study of a proactive deprescribing intervention is different from previous studies and addresses five critical factors identified by prescribers and patients as being key to success,… read more.

New study provides first published examples of medication deprescribing protocols for type 2 diabetes

Written by | 25 Apr 2023

A qualitative case series research study sponsored by the American College of Lifestyle Medicine and published in Clinical Diabetes provides the first published examples of protocols to help guide clinical decision making on… read more.

Barriers and enablers for deprescribing

Written by | 25 Apr 2023

There is no ‘one-size-fits-all’ deprescribing intervention and a good understanding of the barriers and enablers to effective deprescribing is needed, according to Debi Bhattacharya, Professor of Behavioural Medicine… read more.

Deprescribing – reactive and proactive

Written by | 24 Apr 2023

Debi Bhattacharya is Professor of Behavioural Medicine at the University of Leicester, UK. As a former primary care pharmacist, she has experience of both practice and research into… read more.

Pharmacist-based deprescribing successfully reduced older adults’ exposure to anticholinergic drugs

Written by | 22 Jul 2022

Anticholinergics, a class of drugs frequently prescribed for depression, urinary incontinence and many other conditions common in older adults, affect the brain by blocking acetylcholine, a nervous system… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.